What challenge does the lack of licensing or registration for OTC-only wholesalers create?

What challenge does the lack of licensing or registration for OTC-only wholesalers create?

• A. It makes authentication more difficult
• B. It improves supply chain speed
• C. It guarantees safety
• D. It reduces compliance cost

Answer: (A)

Licensing or registration provides verifiable credentials and a clear record of who is authorized to distribute medicines. When a wholesaler is licensed, regulators keep track of who they are, what products they can handle, and their compliance history. This makes it possible for pharmacists, manufacturers, and other stakeholders to verify the supplier’s legitimacy and trust the provenance of the products. Without licensing or registration, there’s no official, centralized way to confirm a wholesaler’s identity or track record. That gaps in verification create real challenges in authenticating sources, increasing the risk that counterfeit, expired, or otherwise unsafe products could slip into the supply chain and that recalls or enforcement actions can be identified and traced. So the main challenge is authentication difficulty due to the absence of legitimate credentialing. The other options don’t fit: licensing isn’t about speeding the supply chain, it doesn’t guarantee safety by itself, and it doesn’t inherently reduce compliance costs.

Licensing or registration provides verifiable credentials and a clear record of who is authorized to distribute medicines. When a wholesaler is licensed, regulators keep track of who they are, what products they can handle, and their compliance history. This makes it possible for pharmacists, manufacturers, and other stakeholders to verify the supplier’s legitimacy and trust the provenance of the products.

Without licensing or registration, there’s no official, centralized way to confirm a wholesaler’s identity or track record. That gaps in verification create real challenges in authenticating sources, increasing the risk that counterfeit, expired, or otherwise unsafe products could slip into the supply chain and that recalls or enforcement actions can be identified and traced.

So the main challenge is authentication difficulty due to the absence of legitimate credentialing. The other options don’t fit: licensing isn’t about speeding the supply chain, it doesn’t guarantee safety by itself, and it doesn’t inherently reduce compliance costs.